tirzepatide patient handout Medical Weight Loss Education Materials Tirzepatide - BIFAT Center

A never-ending bidirectional cross-talk

The FDA has received 520 reports of adverse events linked to semaglutide preparations and 480 reports linked to tirzepatide preparations, highlighting the risks involved

For routine dental work with local anesthesia, continue your regular medication schedule

Although we do not yet have large clinical trials to prove this, smaller studies and observations have suggested that GLP-1 receptor agonists could reduce certain markers of inflammation in the blood

Trulicity starting dose is 0.75 mg once weekly for the first month, which can be increased to 1.5 mg in the second month, and further increased in 1.5 mg increments up to a maximum dose of 4.5 mg weekly based on therapeutic response

Allow 10 seconds after injection before removing the needle to minimize backflow